Article
Brain and plasmatic CLUSTERIN are translational markers of Alzheimer's disease
22 Jun 2024
Abstract excerpt
Early diagnosis of late-onset Alzheimer's disease (AD) by peripheral biomarkers remains a challenge; many have been proposed, but none have been evaluated in a prospective manner. CLUSTERIN (CLU), a chaperone protein expressed in the brain and found in relatively high concentrations in plasma, is a promising candidate. CLU contributes to the elimination of β-amyloid (Aβ), which is associated to neurofibrillary...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
